Regulation of hemolysin in uropathogenic Escherichia coli fine-tunes killing of human macrophages

References

• Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, et al. Genetics of innate immunity and UTI susceptibility. Nat Rev Urol. 2011;8:449–68.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.
   PubMed Web of Science ®Google Scholar
• Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653–60.
   PubMed Web of Science ®Google Scholar
• Aboderin OA, Abdu AR, Odetoyin BW, et al. Antimicrobial resistance in Escherichia coli strains from urinary tract infections. J Natl Med Assoc. 2009;101:1268–73.
   PubMed Web of Science ®Google Scholar
• Hedges S, Anderson P, Lidin-Janson G, et al. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun. 1991;59:421–7.
   PubMed Web of Science ®Google Scholar
• Agace WW, Hedges SR, Ceska M, et al. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest. 1993;92:780–5.
   PubMed Web of Science ®Google Scholar
• Sundac L, Dando SJ, Sullivan MJ, et al. Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis. Pathog Dis. 2016;74. pii: ftw062.
   PubMed Web of Science ®Google Scholar
• Dhakal BK, Mulvey MA. The UPEC pore-forming toxin alpha-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe. 2012;11:58–69.
   PubMed Web of Science ®Google Scholar
• Hilbert DW, Paulish-Miller TE, Tan CK, et al. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect. 2012;14:628–38.
   PubMed Web of Science ®Google Scholar
• Hunstad DA, Justice SS, Hung CS, et al. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun. 2005;73:3999–4006.
   PubMed Web of Science ®Google Scholar
• Loughman JA, Hunstad DA. Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect. 2011;13:555–65.
   PubMed Web of Science ®Google Scholar
• Lau ME, Loughman JA, Hunstad DA. YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration. Infect Immun. 2012;80:4123–32.
   PubMed Web of Science ®Google Scholar
• Schaale K, Peters KM, Murthy AM, et al. Strain- and host species-specific inflammasome activation, IL-1beta release, and cell death in macrophages infected with uropathogenic Escherichia coli. Mucosal Immunol. 2016;9:124–36.
   PubMed Web of Science ®Google Scholar
• Schiwon M, Weisheit C, Franken L, et al. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium. Cell. 2014;156:456–68.
   PubMed Web of Science ®Google Scholar
• Greaney AJ, Leppla SH, Moayeri M. Bacterial Exotoxins and the Inflammasome. Front Immunol. 2015;6:570.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153–8.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Jo EK. NLRP3 inflammasome and host protection against bacterial infection. J Korean Med Sci. 2013;28:1415–23.
   PubMed Web of Science ®Google Scholar
• Waldhuber A, Puthia M, Wieser A, et al. Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. J Clin Invest. 2016;126:2425–36.
   PubMed Web of Science ®Google Scholar
• Subashchandrabose S, Mobley HL. Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol Spectr. 2015;3. doi:10.1128/microbiolspec.UTI-0015-2012
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Totsika M, Mansfield KJ, et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev. 2012;36:616–48.
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–84.
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Mysorekar IU, Chen SL, et al. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol. 2008;67:116–28.
   PubMed Web of Science ®Google Scholar
• Welch RA. Uropathogenic Escherichia coli-Associated Exotoxins. Microbiol Spectr. 2016;4. doi:10.1128/microbiolspec.UTI-0011-2012
   PubMed Web of Science ®Google Scholar
• Felmlee T, Pellett S, Welch RA. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J Bacteriol. 1985;163:94–105.
   PubMed Web of Science ®Google Scholar
• Lim KB, Walker CR, Guo L, et al. Escherichia coli alpha-hemolysin (HlyA) is heterogeneously acylated in vivo with 14-, 15-, and 17-carbon fatty acids. J Biol Chem. 2000;275:36698–702.
   PubMed Web of Science ®Google Scholar
• Stanley P, Packman LC, Koronakis V, et al. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. Science. 1994;266:1992–6.
   PubMed Web of Science ®Google Scholar
• Wandersman C, Delepelaire P. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci U S A. 1990;87:4776–80.
   PubMed Web of Science ®Google Scholar
• Welch RA. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991;5:521–8.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Kuznetsova E, Proudfoot M, Gonzalez CF, et al. Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family. J Biol Chem. 2006;281:36149–61.
   PubMed Web of Science ®Google Scholar
• Pellett S, Boehm DF, Snyder IS, et al. Characterization of monoclonal antibodies against the Escherichia coli hemolysin. Infect Immun. 1990;58:822–7.
   PubMed Web of Science ®Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248–55.
   PubMed Web of Science ®Google Scholar
• Felmlee T, Pellett S, Lee EY, et al. Escherichia coli hemolysin is released extracellularly without cleavage of a signal peptide. J Bacteriol. 1985;163:88–93.
   PubMed Web of Science ®Google Scholar
• Chen KW, Gross CJ, Sotomayor FV, et al. The neutrophil NLRC4 inflammasome selectively promotes IL-1beta maturation without pyroptosis during acute Salmonella challenge. Cell Rep. 2014;8:570–82.
   PubMed Web of Science ®Google Scholar
• Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301:105–7.
   PubMed Web of Science ®Google Scholar
• Bokil NJ, Totsika M, Carey AJ, et al. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology. 2011;216:1164–71.
   PubMed Web of Science ®Google Scholar
• Marrs CF, Zhang L, Tallman P, et al. Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol. 2002;51:138–42.
   PubMed Web of Science ®Google Scholar
• Cooke EM, Ewins SP. Properties of strains of Escherichia coli isolated from a variety of sources. J Med Microbiol. 1975;8:107–11.
   PubMed Web of Science ®Google Scholar
• Bien J, Sokolova O, Bozko P. Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. Int J Nephrol. 2012;2012:681473.
   PubMedGoogle Scholar
• Gadeberg OV, Larsen SO. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Correlation with Size of Alpha-Hemolysin Production APMIS. 1988;96:337–41.
   Google Scholar
• Smith YC, Grande KK, Rasmussen SB, et al. Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells. Infect Immun. 2006;74:750–7.
   PubMed Web of Science ®Google Scholar
• Smith YC, Rasmussen SB, Grande KK, et al. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun. 2008;76:2978–90.
   PubMed Web of Science ®Google Scholar
• Mansson LE, Melican K, Boekel J, et al. Real-time studies of the progression of bacterial infections and immediate tissue responses in live animals. Cell Microbiol. 2007;9:413–24.
   PubMed Web of Science ®Google Scholar
• Wiles TJ, Dhakal BK, Eto DS, et al. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. Mol Biol Cell. 2008;19:1427–38.
   PubMed Web of Science ®Google Scholar
• Nagamatsu K, Hannan TJ, Guest RL, et al. Dysregulation of Escherichia coli alpha-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc Natl Acad Sci U S A. 2015;112:E871–80.
   PubMed Web of Science ®Google Scholar
• Bhakdi S, Greulich S, Muhly M, et al. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med. 1989;169:737–54.
   PubMed Web of Science ®Google Scholar
• Suttorp N, Floer B, Schnittler H, et al. Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun. 1990;58:3796–801.
   PubMed Web of Science ®Google Scholar
• Cavalieri SJ, Snyder IS. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro. Infect Immun. 1982;37:966–74.
   PubMed Web of Science ®Google Scholar
• Jonas D, Schultheis B, Klas C, et al. Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes. Infect Immun. 1993;61:1715–21.
   PubMed Web of Science ®Google Scholar
• Rider P, Carmi Y, Guttman O, et al. IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol. 2011;187:4835–43.
   PubMed Web of Science ®Google Scholar
• Leeds JA, Welch RA. RfaH enhances elongation of Escherichia coli hlyCABD mRNA. J Bacteriol. 1996;178:1850–7.
   PubMed Web of Science ®Google Scholar
• Koonin EV, Tatusov RL. Computer analysis of bacterial haloacid dehalogenases defines a large superfamily of hydrolases with diverse specificity. Application of an iterative approach to database search. J Mol Biol. 1994;244:125–32.
   PubMed Web of Science ®Google Scholar
• Lawhorn BG, Gerdes SY, Begley TP. A genetic screen for the identification of thiamin metabolic genes. J Biol Chem. 2004;279:43555–9.
   PubMed Web of Science ®Google Scholar
• Bailey MJ, Koronakis V, Schmoll T, et al. Escherichia coli HlyT protein, a transcriptional activator of haemolysin synthesis and secretion, is encoded by the rfaH (sfrB) locus required for expression of sex factor and lipopolysaccharide genes. Mol Microbiol. 1992;6:1003–12.
   PubMed Web of Science ®Google Scholar
• Leeds JA, Welch RA. Enhancing transcription through the Escherichia coli hemolysin operon, hlyCABD: RfaH and upstream JUMPStart DNA sequences function together via a postinitiation mechanism. J Bacteriol. 1997;179:3519–27.
   PubMed Web of Science ®Google Scholar
• Bailey MJ, Hughes C, Koronakis V. RfaH and the ops element, components of a novel system controlling bacterial transcription elongation. Mol Microbiol. 1997;26:845–51.
   PubMed Web of Science ®Google Scholar
• Nagy G, Dobrindt U, Schneider G, et al. Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. Infect Immun. 2002;70:4406–13.
   PubMed Web of Science ®Google Scholar
• Barbieri NL, Nicholson B, Hussein A, et al. FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli. Infect Immun. 2014;82:5086–98.
   PubMed Web of Science ®Google Scholar
• Mobley HL, Green DM, Trifillis AL, et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun. 1990;58:1281–9.
   PubMed Web of Science ®Google Scholar
• Kakkanat A, Phan MD, Lo AW, et al. Novel genes associated with enhanced motility of Escherichia coli ST131. PLoS One. 2017;12:e0176290.
   PubMed Web of Science ®Google Scholar
• Phan MD, Peters KM, Sarkar S, et al. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet. 2013;9:e1003834.
   PubMed Web of Science ®Google Scholar
• Allsopp LP, Beloin C, Ulett GC, et al. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun. 2012;80:321–32.
   PubMed Web of Science ®Google Scholar
• Langridge GC, Phan MD, Turner DJ, et al. Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res. 2009;19:2308–16.
   PubMed Web of Science ®Google Scholar
• Hohenhaus DM, Schaale K, Le Cao KA, Seow V, et al. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation. Immunobiology. 2013;218:1345–53.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
   PubMed Web of Science ®Google Scholar